Interpretation of breast MRI: Correlation of kinetic and morphological parameters with pathological findings

Magnetic Resonance in Medical Sciences

Volumn 3, Issue 4, 2004, Pages 189-197

  Tozaki, Mitsuhiro ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast neoplasm; Contrast enhancement kinetics; Interpretation; MR imaging; Tissue characterization

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

BREAST TUMOR; FEMALE; HUMAN; IMAGE ENHANCEMENT; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY;

BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY;

EID: 26944460026     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.3.189     Document Type: Review

References (27)

1. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001; 220:13-30.
2. Heywang SH, Hahn D, Schmidt H, et al. MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 1986; 10:199-204.
3. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 1989; 170:681-686.
4. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology, 1993; 187:493-501.
5. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 1994; 193:777-781.
6. Heywang-Kobrunner SH, Viehweg P, Heinig A, Kuchler C. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur Radiol 1997; 24:94-108.
7. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breathhold examination. Radiology 1999; 212:876-884.
8. Tozaki M, Fukuda Y, Fukuda K, Kawakami M. Diagnosis of breast cancer extent using 3D-dynamic MR imaging with a volumetric interpolated examination. Jpn J Magn Reson Med 2002; 22: 140-146. (in Jpse. with English abstract)
9. Nishikawa K, Tozaki M, Takimoto T, et al. Optimization of 3D-VIBE for MR mammography: phantom study and clinical application. Jpn J Magn Reson Med 2003; 23:92-98. (in Jpse. with English abstract)
10. Nishikawa K, Tozaki M, Fukuda K. Supine MR mammography with parallel imaging techniques. Jpn J Magn Reson Med 2004; 24:34-39. (in Jpse. with English abstract)
11. American College of Radiology. Breast imaging reporting and data system (BI-RADS), 4th ed. Reston, VA: American College of Radiology, 2003.
12. Schnall MD, Ikeda DM. Lesion Diagnosis Working Group on Breast MR. J Magn Reson Imaging 1999; 10:982-990.
13. Ikeda DM, Hylton NM, Kinkel K, et al. Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 2001; 13:889-895.
14. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology, 1999; 211:101-110.
15. Kinkel K, Helbich TH, Esserman LJ, et al. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. AJR 2000; 175:35-43.
16. Fischer DR, Baltzer P, Malich A, et al. Is the "blooming sign" a promising additional tool to determine malignancy in MR mammography? Eur Radiol 2004; 14:394-401.
17. Nunes LW, SchnallMD, Orel SG, et al. Breast MR imaging: interpretation model. Radiology 1997; 202:833-841.
18. Nunes LW, Schnall MD, Orel SG. Update of breast MR imaging architectural interpretation model. Radiology, 2000; 219:484-494.
19. Wedegartner U, Bick U, Wortler K, Rummeny E, Bongartz G. Differentiation between benign and malignant findings on MR-mammography: usefulness of morphological criteria. Eur Radiol 2001; 11:1645-1650.
20. Szabo BK, Aspelin P, Wiberg MK, Bone B. Dynamic MR imaging of the breast. Analysis of kinetic and morphologic diagnostic criteria. Acta Radiol 2003; 44:379-386.
21. Tozaki M, Igarashi T, Matsushima S, Fukuda K. High-spatial-resolution MR imaging of focal breast masses: interpretation model based on kinetic and morphological parameters. Rad Med 2005; 23:43-50.
22. Orel SG, Schnall MD, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994; 190:485-493.
23. Buadu LD, Murakami J, Murayama S, et al. Patterns of peripheral enhancement in breast masses: correlation of findings on contrast medium enhanced MRI with histologic features and tumor angiogenesis. J Comput Assist Tomogr 1997; 21: 421-430.
24. Kuwada T, Tozaki M, Harada J. Evaluation of enhancement patterns using three-dimensional dynamic contrast-enhanced MR imaging in 209 cases of breast cancer. Nippon Igaku Hoshasen Gakkai Zasshi 2004; 64:544-551. (in Jpse. with English abstract)
25. Kawashima M, Tamaki Y, Nonaka T, et al. MR imaging of mucinous carcinoma of the breast. AJR 2002; 179:179-183.
26. Hochman MG, Orel SG, Powell CM, Schnall MD, Reynolds CA, White LN. Fibroadenomas: MR imaging appearances with radiologic-histopathologic correlation. Radiology 1997; 204:123-129.
27. 2-weighted images: correlation with histopathology. Nippon Igaku Hoshasen Gakkai Zasshi 2004; 64:99-106. (in Jpse. with English abstract)